Innate Pharma SA announces 4.4 million Euros in turnover for the first semester of 2008.
Cash, cash equivalents and current financial instruments at the end of June 2008 amounted to 43.0 million euros. The Company updates on the acquisition of its new corporate headquarters during the second quarter of 2008.
| PR in english | 85.19 KB |
| CP en français | 86.28 KB |